環(huán)保在線>產(chǎn)品庫>生物試劑>生物檢測試劑>標(biāo)準(zhǔn)品/對照品>>*雜質(zhì) 提供圖譜

*雜質(zhì) 提供圖譜

參考價	面議

參考價

面議

具體成交價以合同協(xié)議為準(zhǔn)

公司名稱鄭州艾利蒙生物科技有限公司
品牌
型號
所在地鄭州市
廠商性質(zhì)生產(chǎn)廠家
更新時間2017/12/14 12:40:12
訪問次數(shù)621

產(chǎn)品標(biāo)簽:

*雜質(zhì)利拉列汀雜質(zhì)*雜質(zhì)對照品 *雜質(zhì)標(biāo)準(zhǔn)品利拉列汀雜質(zhì)對照品

在線詢價收藏產(chǎn)品點擊查看電話

索取相關(guān)資料

公司介紹主營產(chǎn)品

鄭州艾利蒙生物科技有限公司是一家專注于醫(yī)藥標(biāo)準(zhǔn)品、化工環(huán)境標(biāo)準(zhǔn)品、雜質(zhì)對照品、醫(yī)藥中間體、進出口試劑及耗材的高科技公司。代理品牌：中檢所CP, 歐洲藥典EP, 美國藥典USP, 英國藥典BP, 日本藥典JP, 英國*實驗室LGC, 美國Accustandard標(biāo)準(zhǔn)品, 美國ChemService標(biāo)準(zhǔn)品, 德國Dr.Ehrenstorfer標(biāo)準(zhǔn)品, 加拿大TRC, TLC藥物標(biāo)準(zhǔn)品, MOLCAN藥物標(biāo)準(zhǔn)品, NIBSC英國國家生物制品檢定所, 美國Sigma-Aldrich公司, 美國ChromaDex中草藥標(biāo)準(zhǔn)品, 瑞士CaroteNature類胡蘿卜素標(biāo)準(zhǔn)品, 法國Extrasynthese中草藥標(biāo)準(zhǔn)品, NIST美國國家標(biāo)準(zhǔn)局標(biāo)準(zhǔn)品, IRRM歐洲標(biāo)準(zhǔn)局標(biāo)準(zhǔn)品等。產(chǎn)品種類齊全，到貨迅速。

鄭州艾利蒙生物科技有限公司提供以下雜質(zhì)對照品，并可接受定制：西洛多辛雜質(zhì)，LCZ696雜質(zhì)，盧帕他定雜質(zhì)，AZD-9291雜質(zhì)，曲格列汀雜質(zhì)，*雜質(zhì)，*雜質(zhì)，西格列汀雜質(zhì)，*雜質(zhì)，奧貝膽酸雜質(zhì)，艾曲波帕雜質(zhì)，帕布昔利布雜質(zhì)，普卡比利雜質(zhì)，*雜質(zhì)，尼達尼布雜質(zhì)，魯索替尼雜質(zhì)，依美斯汀雜質(zhì)，依魯替尼雜質(zhì)，恩雜魯胺雜質(zhì)，阿塞那平雜質(zhì)，*雜質(zhì)，沙格列汀雜質(zhì)，普拉克索雜質(zhì)，*雜質(zhì)，帕洛諾司瓊雜質(zhì)，*雜質(zhì)，依折麥布雜質(zhì)，米拉貝隆雜質(zhì)，*雜質(zhì)，*雜質(zhì)，依托考昔雜質(zhì)，*雜質(zhì)，埃索美拉唑雜質(zhì)，*雜質(zhì)等

展開顯示更多內(nèi)容

醫(yī)藥標(biāo)準(zhǔn)品，雜質(zhì)對照品

產(chǎn)品簡介在線詢價

*雜質(zhì) 提供圖譜
純度高，發(fā)貨快，雜質(zhì)種類齊全，提供證書圖譜，接受定制。
10mg/25mg/50mg/100mg及更大包裝可選。

*雜質(zhì) 提供圖譜產(chǎn)品信息

*雜質(zhì) 提供圖譜?? 產(chǎn)品介紹：

所有雜質(zhì)均隨貨提供CoA證書，HPLC，MS，HNMR圖譜等。

雜質(zhì)種類齊全，并可提供雜質(zhì)定制合成服務(wù)，歡迎提供所需結(jié)構(gòu)式詳詢。

*雜質(zhì) 提供圖譜??? 產(chǎn)品信息請：

任：；；

國產(chǎn)進口品牌皆有銷售，部分雜質(zhì)*備有庫存，可快速發(fā)貨，并可定制合成。

?? 雜質(zhì)詳情：

中文名稱	英文名稱
*標(biāo)準(zhǔn)品	Linagliptin
*雜質(zhì)1	2-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide
*雜質(zhì)2	(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
*雜質(zhì)3	N-Phthalimide-linagliptin
*雜質(zhì)4	N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide
*雜質(zhì)5	(R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid
*雜質(zhì)6	8-((R)-3-aminopiperidin-1-yl)-7-((R)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione compound with 8-((R)-3-aminopiperidin-1-yl)-7-((S)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (1:1)
*雜質(zhì)7	Linagliptin Diene Impurity
*雜質(zhì)8	Linagliptin Acetamide
*雜質(zhì)9	(R)-tert-butyl (1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
*雜質(zhì)10	(R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
*雜質(zhì)11	8-bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
*雜質(zhì)12	(R)-tert-butyl (1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
*雜質(zhì)13	(R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
*雜質(zhì)14	(R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione
*雜質(zhì)15	(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide
*雜質(zhì)16	(S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
*雜質(zhì)17	(S)-Linagliptin
*雜質(zhì)18	N-(2-acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide
*雜質(zhì)19	(R)-tert-butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
*雜質(zhì)20	(R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide
*雜質(zhì)21	(R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
*雜質(zhì)22	(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
*雜質(zhì)23	(S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
*雜質(zhì)24	(R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
*雜質(zhì)25	(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide

鄭州艾利蒙生物科技有限公司除國產(chǎn)雜質(zhì)對照品外，代理有加拿大TLC雜質(zhì)對照品，TRC雜質(zhì)對照品，MC雜質(zhì)對照品，英國NIBSC標(biāo)準(zhǔn)品，美國CIL同位素標(biāo)準(zhǔn)品，NIST標(biāo)準(zhǔn)物質(zhì)，歐洲標(biāo)準(zhǔn)局IRMM標(biāo)準(zhǔn)物質(zhì)等，原廠訂貨，質(zhì)量保證。

?? 美國劍橋CIL標(biāo)準(zhǔn)品部分產(chǎn)品列表：

SNLM-3984-PK	TIN-112 METAL (112Sn)
EC-1415-1.2	2,3,3',5,5'-PENTACB (PCB-111) (13C12, 99%) 40+/-2 UG/ML IN NONANE
DLM-9126-0.005	VITAMIN E (ALPHA-TOCOPHEROL) (5-METHYL-D3;7-METHYL-D3,98%)
DLM-294-25	NITROBENZENE-D5 (D, 99%)
T-030	TRAZODONE: HCL UNLABELED 1 MG/ML AS FREE BASE IN METHANOL
CLM-1160-0.5	ACETIC ANHYDRIDE (2,2'-13C2, 99%)
EDF-5409	BROMODIOXIN/FURAN SYRINGE SPIKE (13C12, 99%)
CLM-8824-PK	IODOACETIC ACID (13C2, 99%)
M-085	MORPHINE (D6, 98%) 100 UG/ML IN METHANOL
CLM-2436-0	ACETAMINOPHEN (CARBONYL-13C, 99%)
EDF-2681	SUPPLEMENTAL INTERNAL STANDARD SOLUTION (13C12, 99%)
EDF-4095	MODIFIED METHOD 8280 CALIBRATION SOLUTIONS
NLM-177-PK	AMMONIUM ACETATE (15N, 98%+)
PCB-178	2,2',3,3',5,5',6-HEPTACB UNLABELED 35 UG/ML IN ISOOCTANE
EC-5372-1/10X-10	EN-1948-4 WHO PCB EXTRACTION SPIKE (13C12, 99%) 10 NG/ML IN NONANE
DLM-1063-10	POTASSIUM DIDEUTERIUM PHOSPHATE (D2, 98%)
DLM-170-0.05	DIETHYLSTILBESTROL (CIS/TRANS MIX) (RING-3,3',5,5'-DIETHYL-1,1,1',1'-D8, 98%)
CLM-1604-0	DIFLUOROMETHANE (13C, 99%)
ED-1440	2,3,7,8-TETRABROMODIBENZO-P-DIOXIN (13C12, 99%) 5 UG/ML IN NONANE
CLM-2093-MPT-PK	ALPHA-KETOISOCAPROIC ACID, SODIUM SALT (1-13C, 99%) MICROBIOLOGICAL/PYROGEN TESTED
CLM-1189-PK	D-MANNITOL (1-13C, 98%)
DLM-91	2 mM SUCROSE + 0.5 mM DSS + 2 mM NAN3 IN 90% H2O/10% D2O H2O:D2O=V/V
CLM-3706-MPT-PK	SODIUM D-3-HYDROXYBUTYRATE (2,4-13C2, 99%) MICROBIOLOGICAL/PYROGEN TESTED
ULM-4559-1.2	P-N-NONYLPHENOL UNLABELED 100 UG/ML IN NONANE
DLM-45-PK	SODIUM DEUTEROXIDE (D, 99.5%) 40% IN D2O